The drug, INS018 055, which was created using generative AI, has been given to patients for the first time in the Phase II clinical trial.
Ensysce Biosciences (ENSC) Reports New Clinical Results from Trials PF614-102 and PF614-MPAR-101
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Ensysce Biosciences Announces New Clinical Results from Trials PF614-102 and PF614-MPAR-101
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.
Ensysce Biosciences (ENSC) Announces New Clinical Results from Trials PF614-102 and PF614-MPAR-101
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.